- Jason Edward Ochs
- July 19, 2017
If one were to watch or read an advertisement for Xarelto, one would likely think it perfectly safe to use for various medical applications. These would include: Blood thinning, including clotting prevention Stroke prevention Systemic and pulmonary embolism prevention Deep…
- Jason Edward Ochs
- July 17, 2017
The US has been hit very hard by the recent opioid crisis. Deaths from opioid-related overdose have quadrupled since 2003, with 33,000 deaths in the nation last year alone. But nowhere in the US has been affected as drastically as…
- Jason Edward Ochs
- July 8, 2017
It happened in the 90’s when state attorney generals across the country were concerned with the costs associated with tobacco use and smoking, and they turned to litigation to help solve the economic drain. Could the recent AG lawsuits against…
- Jason Edward Ochs
- June 4, 2017
In a continued effort to bring to you updates in regards to what we have previously blogged could very well be a record-setting-year for Johnson & Johnson with respect to jury verdicts, we wanted to report the latest in our…
- Jason Edward Ochs
- May 24, 2017
The Food and Drug Administration has issued a safety alert warning of the increased risk of pancreatitis in patients taking the irritable-bowel syndrome (IBS) drug Verbizi (eluxadoline). Verbizi is most often prescribed for IBS with diarrhea in both men and…
- Jason Edward Ochs
- May 19, 2017
The US Food and Drug Administration has issued a warning regarding the relatively new diabetes 2 drug most notably known as Invokana regarding leg and toe amputations. The warning states: Based on new data from two large clinical trials, the…
- Jason Edward Ochs
- May 9, 2017
A new study in the British Journal of Medicine has resurrected the debate and concern over cardiovascular risk linked to the commonly utilized pain relievers known as nonsteroidal anti-inflammatory drugs, or NSAIDs. The study involved a systematic review of studies…
- Jason Edward Ochs
- April 20, 2017
Two bellwether trials are set to begin in the mass action regarding the pharmaceutical drug Xarelto in the coming week. The first will start next week in the Eastern District of Louisiana. To date there are more than 16,000 cases…
- Jason Edward Ochs
- April 13, 2017
In 2002, Bayer Pharmaceutical invented a relatively non-invasive form of permanent birth control, known as Essure. The Essure procedure can be done in several minutes by a gynecologist, has a recovery time of approximately two days, and does not require…
- Jason Edward Ochs
- April 13, 2017
The awareness of talculm powder and the alleged link to ovarian cancer is spreading, but few consumers realize the strength of the science behind the two. Among the science linking the two include 22 different studies. Since as early as…
